JP2005519123A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519123A5 JP2005519123A5 JP2003573134A JP2003573134A JP2005519123A5 JP 2005519123 A5 JP2005519123 A5 JP 2005519123A5 JP 2003573134 A JP2003573134 A JP 2003573134A JP 2003573134 A JP2003573134 A JP 2003573134A JP 2005519123 A5 JP2005519123 A5 JP 2005519123A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- protein
- antigen
- vegetative cell
- bacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0205376.7A GB0205376D0 (en) | 2002-03-07 | 2002-03-07 | Spore germination |
| PCT/GB2003/000966 WO2003074681A1 (en) | 2002-03-07 | 2003-03-07 | Recombinant spores |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519123A JP2005519123A (ja) | 2005-06-30 |
| JP2005519123A5 true JP2005519123A5 (https=) | 2006-04-27 |
Family
ID=9932499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003573134A Withdrawn JP2005519123A (ja) | 2002-03-07 | 2003-03-07 | 組換え胞子 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050287168A1 (https=) |
| EP (1) | EP1495110A1 (https=) |
| JP (1) | JP2005519123A (https=) |
| KR (1) | KR20040099293A (https=) |
| CN (1) | CN1639322A (https=) |
| AU (1) | AU2003214391A1 (https=) |
| GB (1) | GB0205376D0 (https=) |
| RU (1) | RU2004129739A (https=) |
| WO (1) | WO2003074681A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0503509D0 (en) * | 2005-02-19 | 2005-03-30 | New Royal Holloway & Bedford | An improved delivery agent |
| JP2008231063A (ja) * | 2007-03-22 | 2008-10-02 | Takano Foods Kk | 納豆菌ワクチン |
| US9610333B2 (en) * | 2008-07-11 | 2017-04-04 | Tufts University | Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines |
| WO2010006326A2 (en) * | 2008-07-11 | 2010-01-14 | Tufts University | Methods and compositions for spore-based vaccines |
| WO2011111783A1 (ja) * | 2010-03-12 | 2011-09-15 | カルピス株式会社 | 大腸におけるビフィズス菌の増加及び減少抑制剤 |
| EP4077359B1 (en) | 2019-12-18 | 2026-03-18 | LivingMed Biotech S.R.L. | Genetically modified clostridium strains and uses thereof |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668255A (en) * | 1984-06-07 | 1997-09-16 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| DE69002817T2 (de) * | 1989-11-28 | 1993-12-09 | Wellcome Found | Vakzine. |
| US6280721B1 (en) * | 1989-12-18 | 2001-08-28 | Valent Biosciences, Inc. | Production of Bacillus thuringiensis integrants |
| JP3415145B2 (ja) * | 1991-03-05 | 2003-06-09 | ザ ウエルカム ファウンデーション リミテッド | 弱毒化細菌における組換えタンパク質の発現 |
| US5340577A (en) * | 1992-07-29 | 1994-08-23 | The United States Of America, As Represented By The Secretary Of Agriculture | Probiotic for control of salmonella |
| GB9401787D0 (en) * | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccine compositions |
| GB9400650D0 (en) * | 1994-01-14 | 1994-03-09 | Smithkline Beecham Biolog | Expression of surface lazer proteins |
| US5533973A (en) * | 1995-01-13 | 1996-07-09 | Abbott Laboratories | Alteration of nutritional product during enteral tube feeding |
| US5531681A (en) * | 1995-01-13 | 1996-07-02 | Abbott Laboratories | Apparatus for altering composition of nutritional product during enteral tube feeding |
| US5531734A (en) * | 1995-01-13 | 1996-07-02 | Abbott Laboratories | Method of altering composition of nutritional product during enteral tube feeding |
| US5800821A (en) * | 1995-03-10 | 1998-09-01 | New England Medical Center Hospitals, Inc. | Bacterial spores as a heat stable vaccine delivery system |
| US5707353A (en) * | 1995-12-21 | 1998-01-13 | Abbott Laboratories | Oral administration of beneficial agents |
| WO1997035612A1 (fr) * | 1996-03-23 | 1997-10-02 | The Research Foundation For Microbial Diseases Of Osaka University | Antigene a fragment fonctionnel de la toxine du tetanos, et vaccin contre le tetanos |
| US5707127A (en) * | 1996-06-26 | 1998-01-13 | Kain; Meira | Three-dimensional image viewing apparatus |
| DK0862863T4 (da) * | 1997-01-09 | 2008-12-01 | Nestle Sa | Kornprodukt indeholdende probiotika |
| US7923216B2 (en) * | 1997-08-14 | 2011-04-12 | Institut Pasteur | In vivo modulation of neuronal transport |
| US7923015B2 (en) * | 1997-08-14 | 2011-04-12 | Institut Pasteur | Methods for direct visualization of active synapses |
| US6730499B1 (en) * | 1998-07-03 | 2004-05-04 | Research Corporation Technologies, Inc. | Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1 |
| US6080401A (en) * | 1998-11-19 | 2000-06-27 | Reddy; Malireddy S. | Herbal and pharmaceutical drugs enhanced with probiotics |
| US6090417A (en) * | 1999-03-24 | 2000-07-18 | Kraft Foods, Inc. | Nutritional fortification of natural cheese and method of making |
| US7186560B2 (en) * | 1999-09-21 | 2007-03-06 | Rutgers, The State University Of New Jersey | High level expression of immunogenic proteins in the plastids of higher plants |
| GB0009470D0 (en) * | 2000-04-17 | 2000-06-07 | Univ Southampton | Materials and methods relating to immune responses to fusion proteins |
| EP1292686A1 (en) * | 2000-06-07 | 2003-03-19 | Smittskyddsinstitutet | Gene expression cassette and its use |
| US6881558B1 (en) * | 2000-06-26 | 2005-04-19 | The Trustees Of The University Of Pennsylvania | Expression system for cloning toxic genes |
| US20030165538A1 (en) * | 2000-06-26 | 2003-09-04 | Maxygen Incorporated | Methods and compositions for developing spore display systems for medicinal and industrial applications |
| US20020150594A1 (en) * | 2000-06-26 | 2002-10-17 | Maxygen, Inc. | Methods and compositions for developing spore display systems for medicinal and industrial applications |
| KR20020045400A (ko) * | 2000-12-08 | 2002-06-19 | 반재구 | 포자 표면발현 방법 |
| GB0130789D0 (en) * | 2001-12-21 | 2002-02-06 | King S College London | Application of spores |
-
2002
- 2002-03-07 GB GBGB0205376.7A patent/GB0205376D0/en not_active Ceased
-
2003
- 2003-03-07 AU AU2003214391A patent/AU2003214391A1/en not_active Abandoned
- 2003-03-07 WO PCT/GB2003/000966 patent/WO2003074681A1/en not_active Ceased
- 2003-03-07 EP EP03709962A patent/EP1495110A1/en not_active Withdrawn
- 2003-03-07 RU RU2004129739/13A patent/RU2004129739A/ru not_active Application Discontinuation
- 2003-03-07 JP JP2003573134A patent/JP2005519123A/ja not_active Withdrawn
- 2003-03-07 CN CNA038054248A patent/CN1639322A/zh active Pending
- 2003-03-07 US US10/506,749 patent/US20050287168A1/en not_active Abandoned
- 2003-03-07 KR KR10-2004-7013611A patent/KR20040099293A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Subramanian et al. | Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: from nasopharyngeal colonizer to intracellular pathogen | |
| ATE513560T1 (de) | Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird | |
| WO2002000232A3 (en) | Methods and compositions for developing spore display systems for medicinal and industrial applications | |
| Ishihara | Virulence factors of Treponema denticola. | |
| IL264925A (en) | Isolated or recombinant proteins that induce an immune response against S. PYOGENES, preparations containing them and their uses | |
| BR0314060A (pt) | Bactéria probiótica: lactobacillus fermentum | |
| NO20053142L (no) | Allergen doseringsform. | |
| NO20072906L (no) | Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn | |
| WO2002047668A3 (de) | Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide | |
| Converso et al. | Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice | |
| JP2005519123A5 (https=) | ||
| ATE255905T1 (de) | Iscom oder iscom-matrix, welche einen gegen die schleimhaut gerichteten wirkstoff und ein antigen enthält | |
| EP2502998A3 (en) | Recombinant toxin A/ToxinB vaccine against clostridium difficile | |
| ZA200208761B (en) | Pharmaceutical form of administration for peptides, methods for its production and use. | |
| NO20030231L (no) | Proteinkompleks som fungerer som en vehikkel for oralt administrerbare medikamenter | |
| AU2001269927A1 (en) | Thrombomodulin analogs for pharmaceutical use | |
| ATE404214T1 (de) | Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält | |
| NO20070775L (no) | Baerer for medikamenter for oppnaelse av oral biotilgjengelighet | |
| BRPI0413509A (pt) | uso de antibióticos de quinolona | |
| Winther et al. | Probiotic Bacillus spp. enhance TLR3‐mediated TNF signalling in macrophages | |
| NO20014788D0 (no) | En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider | |
| DE69902271D1 (de) | Einnehmbare produkte | |
| DK0983361T3 (da) | Bakterielle pheromoner og anvendelser deraf | |
| Vaishnavi | Virulence factors associated with clostridiodes difficile: an overview | |
| ATE456659T1 (de) | Streptococcus pyogenes polypeptide und entsprechende dna fragmente |